← 治験一覧に戻る
THS 2.2メントールを用いた曝露低減試験:隔離環境下で5日間、外来環境下で85日間
基本情報
- NCT ID
- NCT01970995
- ステータス
- 完了
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 160
- 治験依頼者名
- Philip Morris Products S.A.
概要
The main goal of the study is to evaluate if the ad libitum use of the THS 2.2 Menthol (mTHS 2.2) for 5 days in confinement and after 85 days of product use in an ambulatory setting, by Japanese adult healthy smokers results in a reduction in the levels of biomarkers of exposure for selected harmful and potentially harmful smoke constituents (HPHCs) compared to smokers continuing smoking their own preferred brand of menthol conventional cigarette (mCC) and smoking abstinence (SA). Smokers who remained abstinent from SA were used as a benchmark to provide context to the exposure reduction.
対象疾患
Smoking
介入
THS 2.2 Menthol (mTHS 2.2)(OTHER)
Smoking Abstinence (SA)(OTHER)
Menthol Conventional Cigarette (mCC)(OTHER)
依頼者(Sponsor)
Philip Morris Products(INDUSTRY)
実施施設 (1)
医療法人社団空と大地 大崎病院東京ハートセンター
Tokyo, Japan